Lee Tien-Li (CIK 1940120) reported 10 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2025-12-12). Recent activity: Buy AARD (7,000 shares), Buy AARD (1,229 shares), Buy AARD (6,500 shares), Buy AARD (3,500 shares), Buy AARD (9,000 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-12-12 | Aardvark Therapeutics, Inc. (AARD) | Chief Executive Officer | Buy | 7,000 | $101,430 |
| 2025-10-16 | Aardvark Therapeutics, Inc. (AARD) | Chief Executive Officer | Buy | 1,229 | $5,211 |
| 2025-09-16 | Aardvark Therapeutics, Inc. (AARD) | Chief Executive Officer | Buy | 6,500 | $61,815 |
| 2025-09-16 | Aardvark Therapeutics, Inc. (AARD) | Chief Executive Officer | Buy | 3,500 | $34,790 |
| 2025-09-12 | Aardvark Therapeutics, Inc. (AARD) | Chief Executive Officer | Buy | 9,000 | $71,190 |
| 2025-09-12 | Aardvark Therapeutics, Inc. (AARD) | Chief Executive Officer | Buy | 6,000 | $46,920 |
| 2025-09-12 | Aardvark Therapeutics, Inc. (AARD) | Chief Executive Officer | Buy | 5,000 | $42,500 |
| 2025-08-29 | Aardvark Therapeutics, Inc. (AARD) | Chief Executive Officer | Buy | 17,209 | $72,966 |
| 2025-02-19 | Aardvark Therapeutics, Inc. (AARD) | Chief Executive Officer | Buy | 41,303 | $0 |
| 2025-02-19 | Aardvark Therapeutics, Inc. (AARD) | Chief Executive Officer | Buy | 16,542 | $264,672 |
Source: SEC Form 4 filings · as of 2025-12-12